Exploring the Potential of Metal-Based Candidate Drugs as Modulators of the Cytoskeleton

Veröffentlichungen: Beitrag in FachzeitschriftReviewPeer Reviewed

Abstract

During recent years, accumulating evidence suggested that metal-based candidate drugs are promising modulators of cytoskeletal and cytoskeleton-associated proteins. This was substantiated by the identification and validation of actin, vimentin and plectin as targets of distinct ruthenium(II)- and platinum(II)-based modulators. Despite this, structural information about molecular interaction is scarcely available. Here, we compile the scattered reports about metal-based candidate molecules that influence the cytoskeleton, its associated proteins and explore their potential to interfere in cancer-related processes, including proliferation, invasion and the epithelial-to-mesenchymal transition. Advances in this field depend crucially on determining binding sites and on gaining comprehensive insight into molecular drug-target interactions. These are key steps towards establishing yet elusive structure-activity relationships.

OriginalspracheEnglisch
Aufsatznummere202300178
FachzeitschriftChemBioChem
Jahrgang24
Ausgabenummer17
DOIs
PublikationsstatusVeröffentlicht - 1 Sep. 2023

ÖFOS 2012

  • 106002 Biochemie
  • 106023 Molekularbiologie
  • 301305 Medizinische Chemie

Zitationsweisen